Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.16% is in line with its 5-year average of 64.60%, near the low end of its 5-year range (55.94%–76.22%).
As of the fiscal period ended Tuesday, March 31, 2026. 2.39% below its 12-month average of 59.58%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
58.16%
GROSS MARGIN AVG TTM
59.58%
GROSS MARGIN AVG 3Y
59.60%
GROSS MARGIN AVG 5Y
64.60%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.39%
CURRENT VS 3Y AVG
-2.42%
CURRENT VS 5Y AVG
-9.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
59.09%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-1.57%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$2.80B
Gross Margin
58.16%
TTM Avg
59.58%
3Y Avg
59.60%
5Y Avg
64.60%
Market Cap
$2.83B
Gross Margin
48.93%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$1.19B
Gross Margin
73.53%
TTM Avg
70.13%
3Y Avg
70.04%
5Y Avg
68.74%
Market Cap
$473.25M
Gross Margin
75.48%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$15.31M
Gross Margin
53.33%
TTM Avg
48.95%
3Y Avg
47.93%
5Y Avg
47.45%
Market Cap
$7.09B
Gross Margin
67.64%
TTM Avg
76.65%
3Y Avg
78.21%
5Y Avg
76.94%
Market Cap
$7.93B
Gross Margin
17.39%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.80B | 58.16% | 59.58% | 59.60% | 64.60% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.83B | 48.93% | 50.81% | 52.12% | 52.25% |
| Teladoc Health, Inc. (TDOC)vs › | $1.19B | 73.53% | 70.13% | 70.04% | 68.74% |
| Shoulder Innovations, Inc. (SI)vs › | $473.25M | 75.48% | 76.74% | 77.57% | 77.57% |
| NRC Health (NRC)vs › | $440.59M | 56.33% | 58.27% | 60.30% | 61.48% |
| 23andMe Holding Co. (ME)vs › | $15.31M | 53.33% | 48.95% | 47.93% | 47.45% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.09B | 67.64% | 76.65% | 78.21% | 76.94% |
| Oscar Health, Inc. (OSCR)vs › | $7.93B | 17.39% | 17.24% | 38.82% | 59.22% |
| Tempus AI, Inc. (TEM)vs › | $8.32B | 63.98% | 62.30% | 54.75% | 44.45% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.03B | 51.87% | 52.87% | 53.77% | 54.60% |
Gross Margin
58.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 58.16% |
| 2025-12-31 | 58.11% |
| 2025-09-30 | 58.80% |
| 2025-06-30 | 61.38% |
| 2025-03-31 | 61.47% |
| 2024-12-31 | 59.21% |
| 2024-09-30 | 55.94% |
| 2024-06-30 | 60.51% |
| 2024-03-31 | 61.81% |
| 2023-12-31 | 59.04% |
| 2023-09-30 | 61.21% |
| 2023-06-30 | 70.03% |
| 2023-03-31 | 69.23% |
| 2022-12-31 | 65.99% |
| 2022-09-30 | 70.53% |
| 2022-06-30 | 69.93% |
| 2022-03-31 | 76.22% |
| 2021-12-31 | 72.26% |
| 2021-09-30 | 70.26% |
| 2021-06-30 | 68.40% |
| 2021-03-31 | 68.21% |
| 2020-12-31 | 63.30% |
| 2020-09-30 | 71.05% |
| 2020-06-30 | 56.30% |
| 2020-03-31 | 64.54% |
| 2019-12-31 | 61.76% |
| 2019-09-28 | 58.51% |
| 2019-06-29 | 58.82% |
| 2019-03-30 | 55.03% |
| 2018-12-31 | 42.30% |
| 2018-09-30 | 52.79% |
| 2018-06-30 | 40.45% |
| 2018-03-31 | 36.68% |
| 2017-12-30 | 25.12% |
| 2017-09-30 | 25.98% |
| 2017-07-01 | 36.34% |
| 2017-04-01 | 30.25% |
